1. Home
  2. ALB vs RGEN Comparison

ALB vs RGEN Comparison

Compare ALB & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALB
  • RGEN
  • Stock Information
  • Founded
  • ALB 1994
  • RGEN 1981
  • Country
  • ALB United States
  • RGEN United States
  • Employees
  • ALB N/A
  • RGEN N/A
  • Industry
  • ALB Major Chemicals
  • RGEN Medical/Dental Instruments
  • Sector
  • ALB Industrials
  • RGEN Health Care
  • Exchange
  • ALB Nasdaq
  • RGEN Nasdaq
  • Market Cap
  • ALB 7.0B
  • RGEN 8.0B
  • IPO Year
  • ALB 1994
  • RGEN N/A
  • Fundamental
  • Price
  • ALB $67.96
  • RGEN $126.96
  • Analyst Decision
  • ALB Hold
  • RGEN Buy
  • Analyst Count
  • ALB 20
  • RGEN 12
  • Target Price
  • ALB $89.25
  • RGEN $170.40
  • AVG Volume (30 Days)
  • ALB 3.3M
  • RGEN 741.9K
  • Earning Date
  • ALB 07-30-2025
  • RGEN 07-29-2025
  • Dividend Yield
  • ALB 2.38%
  • RGEN N/A
  • EPS Growth
  • ALB N/A
  • RGEN N/A
  • EPS
  • ALB N/A
  • RGEN N/A
  • Revenue
  • ALB $5,093,671,000.00
  • RGEN $650,429,000.00
  • Revenue This Year
  • ALB N/A
  • RGEN $13.93
  • Revenue Next Year
  • ALB $10.59
  • RGEN $14.35
  • P/E Ratio
  • ALB N/A
  • RGEN N/A
  • Revenue Growth
  • ALB N/A
  • RGEN 4.88
  • 52 Week Low
  • ALB $49.43
  • RGEN $102.97
  • 52 Week High
  • ALB $113.91
  • RGEN $182.52
  • Technical
  • Relative Strength Index (RSI)
  • ALB 65.00
  • RGEN 53.21
  • Support Level
  • ALB $60.64
  • RGEN $121.44
  • Resistance Level
  • ALB $66.67
  • RGEN $131.43
  • Average True Range (ATR)
  • ALB 2.58
  • RGEN 4.51
  • MACD
  • ALB 0.65
  • RGEN 0.50
  • Stochastic Oscillator
  • ALB 92.56
  • RGEN 65.91

About ALB Albemarle Corporation

Albemarle is one of the world's largest lithium producers. In the lithium industry, the majority of demand comes from batteries, where lithium is used as the energy storage material, particularly in electric vehicles. Albemarle is a fully integrated lithium producer. Its upstream resources include salt brine deposits in Chile and the US and two hard rock mines in Australia, both of which are joint ventures. The company operates lithium refining plants in Chile, the US, Australia, and China. Albemarle is a global leader in the production of bromine, used in flame retardants. It is also a major producer of oil refining catalysts.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: